Categories: News

FUTURE FUND OMAN COMMITS $1.2 BILLION AS $5.2 BILLION INVESTMENT PROGRAM ACCELERATES ECONOMIC DIVERSIFICATION

MUSCAT, Oman, Dec. 17, 2025 /PRNewswire/ — Future Fund Oman announced record activity in 2025, approving 141 projects this year and lifting total commitments to $1.2 billion as the fund accelerates Oman’s economic diversification agenda.  Established by Oman Investment Authority with a capital commitment of $5.2 billion to be deployed over five years, the fund is now one of the region’s fastest-expanding national investment vehicles, with all capital directed toward projects inside Oman and aligned with the priorities of Oman Vision 2040.

- Advertisement -

Investment activity has drawn growing private-sector participation from the United States, United Arab Emirates, Saudi Arabia, Egypt, China, and India. To date, Future Fund Oman has mobilized approximately $2.1 billion in additional private and foreign capital, including eight large-scale projects developed alongside global investors, banks, funds, and family offices. The fund said the rising leverage ratio reflects strengthening international confidence in Oman’s industrial, manufacturing, and clean energy ambitions.

- Advertisement -

Job creation remains a key performance indicator. Projects approved since launch have generated more than 1,400 jobs, with thousands more in progress. Investments span five national priority clusters , energy transition, advanced materials, healthcare, logistics, and information and communications technology, reinforcing the fund’s role in shaping the country’s next phase of economic growth.

- Advertisement -

Flagship developments include a $1.6 billion solar-grade polysilicon manufacturing facility by United Solar, scheduled for completion in 2026. The project has already supported over 1,000 jobs and delivered more than $317 million in in-country value, while also attracting interest from international development finance institutions. Another major project is JA Solar’s six-gigawatt solar cell manufacturing complex in the SOHAR Port and Freezone, a $442 million investment nearing key construction milestones. Once operational, the facility is expected to employ more than 500 people and expand Oman’s foothold in regional clean energy supply chains.

- Advertisement -

Momentum also continues under the fund’s SME and venture capital mandate. Since inception, 132 SME and VC projects have been approved, with $56.7 million committed and $37.4 million deployed through eight specialized vehicles covering pre-seed, seed, growth equity, and SME debt. Application volumes remain strong across both mandates, driven by sustained domestic and international interest in projects linked to industrial modernization, technology development, and clean energy.

- Advertisement -

Since launch, the fund has assessed 828 proposals and approved 141 projects valued at around $3.4 billion, spanning nine major strategic investments and 132 SME and venture capital initiatives. Its dual mandate guides capital toward both large national projects and smaller high-growth businesses, with a targeted 12 percent return and a 40 percent equity ceiling per investment.

- Advertisement -

Media contact:

- Advertisement -

OIA Press Office
Mobile: +968 92278104
Email: Media@oia.gov.om

- Advertisement -

 

- Advertisement -

Photo – https://mma.prnewswire.com/media/2847853/OMAN_INVESTMENT_AUTHORITY.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/future-fund-oman-commits-1-2-billion-as-5-2-billion-investment-program-accelerates-economic-diversification-302644909.html

- Advertisement -
PRNW Agency

Recent Posts

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

3 days ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

1 week ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

1 week ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans…

1 month ago